iMeds.se

Ebastine Teva



PACKAGE LEAFLET: INFORMATION FOR THE USER


Ebastine Teva 10 mg Orodispersible Tablets

Ebastine Teva 20 mg Orodispersible Tablets

Ebastine


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.


What is in this leaflet:

1. What Ebastine Teva is and what it is used for

2. What you need to know before you take Ebastine Teva

3. How to take Ebastine Teva

4. Possible side effects

5. How to store Ebastine Teva

6. Contents of the pack and other information


1. What Ebastine Teva is and what it is used for


Ebastine is an antihistamine that helps relieve allergy symptoms such as sneezing, runny nose, watery eyes and itchy skin rashes.

In adults and children aged 12 years and older Ebastine Teva is used to alleviate the symptoms of seasonal rhinitis (hay fever) and perennial allergic rhinitis, including cases with allergic conjunctivitis.

In adults over the age of 18 years Ebastine Teva 10 mg is also used to alleviate itching and the development of wheals in urticaria (nettle rash).


2. What you need to know before you take Ebastine Teva


Do NOT take Ebastine Teva

If you are allergic to ebastine or any of the other ingredients of this medicine (listed in section 6).


Warnings and precautions


Talk to your doctor before taking Ebastine Teva if;


Children and adolescents

This medicine should only be used by children 12 years of age and over. Do not give this medicine to children under 12 as the safety and efficacy have not been established in this age group.


Other medicines and Ebastine Teva


Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.


Ebastine Teva can affect or be affected by some medicines which contain the following active substance:

- ketoconazole, itraconazole (medicines used to treat fungal infections).

- erythomycin (antibiotic).

- rifampicin (medicine used to treat tuberculosis).


Ebastine Teva with food and drink


You may take Ebastine Teva independently from meal times.


Pregnancy ,breast-feeding and fertility


There is limited experience to date of the safety in humans for the unborn child. For this reason, you should take Ebastine Teva during pregnancy only if your doctor considers that the expected benefit outweighs the possible risks.


Do not take Ebastine Teva if you are breast‑feeding an infant, as it is not known whether the active substance passes into mother’s milk.


If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


Driving and using machines


Most patients treated with Ebastine Teva may drive or carry out other activities that require a good reaction capacity. As with all other medicines, however, you should check your individual reaction after taking Ebastine Teva before you drive or carry out complicated activities, some patients experience sleepiness or dizziness.


Ebastine Teva contains



3. How to take Ebastine Teva


Always take Ebastine Teva exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.


The recommended dose is:


Indication

Age

Dose

Allergic rhinitis


In case of severe symptoms

Children 12 years and above and adults

One Ebastine Teva 10 mg tablet (10 mg ebastine) daily


Two Ebastine Teva 10 mg tablet or one Ebastine Teva 20 mg tablet (20 mg ebastine) once daily

Nettle rash (urticaria)

Adults above 18 years of age

One Ebastine Teva 10 mg tablet (10 mg ebastine) once daily


In patients with impaired kidney function, no dose adjustment is necessary.


In patients with mild to moderately impaired liver function, no dose adjustment is necessary.


There is no experience with doses over 10 mg in patients with severe hepatic impairment; therefore the dose should not exceed 10 mg in these patients.


Do not push the tablet out of the pocket, as this will crush it.

Each strip contains tablets separated in pockets by perforations. Tear off one tablet pocket along the dotted lines (Figure 1)


Carefully peel off the lidding foil, starting in the corner indicated by the arrow (Figures 2 and 3)


Keep your hands dry and take the tablet out of the strip.


Place the tablet on your tongue where it will disperse within seconds: no water or other fluid is required.


You may take Ebastine Teva independently of meal times.


Your doctor will decide on the duration of use.


If you take more Ebastine Teva than you should


There is no special antidote for the active substance ebastine.

If you suspect an overdose with Ebastine Teva, please tell your doctor. Depending on the severity of the intoxication, he/she will initiate the appropriate measures (monitoring of vital body functions, including ECG monitoring for at least 24 hours, symptomatic treatment and gastric lavage), if necessary.


If you forget to take Ebastine Teva


Do not take a double dose to make up for a forgotten dose.


If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


Uncommon side effects may affect up to 1 in 100 people

Sore throat (pharyngitis), runny nose (rhinitis), nose bleeds.


Rare side effects may affect up to 1 in 1,000 people

Drowsiness, Dry mouth.


Very rare side effects may affect up to 1 in 10,000 people


Reportingof side effects

If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet.You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

[To be completed nationally]


5. How to store Ebastine Teva



6. Contents of the pack and other information


What Ebastine Teva contains



What Ebastine Teva looks like and contents of the pack


10 mg: 10, 20, 30, 40, 50, 90, 98 and 100 orodispersible tablets.

20 mg: 10, 15, 20, 30, 40, 50, 98 and 100 orodispersible tablets


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer

<To be completed nationally>


This medicinal product is authorised in the Member States under the following names:

[Name of Member States] [Name of the medicinal product]


This leaflet was last revised in 2014-01-24


9